Status:
COMPLETED
Impact of Pulmonary Follow-up After Stem Cell Graft
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Hematologic Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
Allogeneic hematopoietic stem cell transplantation is the only possible treatment for many malignant and non-malignant hemopathies. The graft-versus-host immunological reaction (GvH) is a frequent and...
Eligibility Criteria
Inclusion
- 18 years of age or older
- patients with a hematopoietic stem cell transplantation
Exclusion
- Death within 100 days post-surgery
Key Trial Info
Start Date :
November 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2017
Estimated Enrollment :
227 Patients enrolled
Trial Details
Trial ID
NCT03349372
Start Date
November 1 2016
End Date
October 31 2017
Last Update
November 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Croix-Rousse Hospital, Hospices Civils de Lyon
Lyon, France, 69004